Glucose Metabolism Disorders  >>  albenatide (CJC-1134-PC)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albenatide (CJC-1134-PC) / ConjuChem, Changshan Kaijiejian Biopharma
NCT01514149: Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Terminated
2
73
US, Canada
CJC-1134-PC Injection, metformin, Weekly placebo for CJC-1134-PC Injection
ConjuChem
Type 2 Diabetes Mellitus (T2DM)
05/12
03/13

Download Options